Invesco
DTIL icon

Invesco’s Precision BioSciences DTIL Stock Holding History

Invesco’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+27,582
New +$194K ﹤0.01% 3563
2023
Q2 		– Sell
-836
Closed -$18.9K – 3880
2023
Q1 		$18.9K Buy
836
+266
+47% +$8.77K ﹤0.01% 3818
2022
Q4 		$20.3K Buy
+570
New +$22.5K ﹤0.01% 3970
2022
Q2 		– Sell
-762
Closed -$71K – 4068
2022
Q1 		$71K Buy
762
+4
+0.5% +$543 ﹤0.01% 3898
2021
Q4 		$168K Sell
758
-48
-6% -$13.4K ﹤0.01% 3819
2021
Q3 		$279K Buy
806
+131
+19% +$44.4K ﹤0.01% 3676
2021
Q2 		$254K Buy
675
+286
+74% +$85.9K ﹤0.01% 3699
2021
Q1 		$121K Buy
+389
New +$136K ﹤0.01% 3739
2020
Q1 		– Sell
-2,216
Closed -$923K – 3660
2019
Q4 		$923K Buy
+2,216
New +$696K ﹤0.01% 3036

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Invesco's DTIL Position: Q2 2026 in Review

Invesco opened a new position in Precision BioSciences (DTIL) in Q2 2026: 27,582 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #3563 among its holdings. This is a return to the name: Invesco previously reported a position in DTIL as recently as Q1 2023.

Invesco first reported a position in DTIL in Q4 2019 and has held it in 9 quarters since. The position peaked at $923K in Q4 2019. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Invesco held 27,582 shares of Precision BioSciences worth $217K as of Q2 2026.
  • Precision BioSciences was a new Invesco position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3563 holding.
  • Invesco first reported a position in Precision BioSciences in Q4 2019 and has held it in 9 quarters since.
  • Invesco's Precision BioSciences position peaked at $923K in Q4 2019.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.